Using the described ex vivo protocol with patient tumour biopsies, we could show that aspirin also caused increased COMMD1 in 3/4 colorectal tumours, again potentially identifying patients that would benefit for aspirin therapy36. This evidence concerns the gene COMMD1 and neoplasm.